Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT04776629 Completed - Clinical trials for Coronary Artery Disease

A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

Start date: June 30, 2021
Phase: Phase 2
Study type: Interventional

The primary purpose of this proof-of-activity, phase 2 trial is to evaluate the safety and activity of orticumab in subjects with moderate to severe psoriasis and cardiometabolic risk factors.

NCT ID: NCT04776577 Completed - Coronary Disease Clinical Trials

Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

In summary, the purpose of the study is to evaluate whether the Wirecath device can be used as a standard pressure wire in a safe and efficient way.

NCT ID: NCT04774861 Completed - Clinical trials for Coronary Artery Disease

Correlation of Cardiac Computed Tomography Angiography Dimensions and Ethnicity in Trinidad

CADET
Start date: August 1, 2020
Phase:
Study type: Observational

The aim of this study is to compare coronary artery dimensions on Cardiac CT angiography amongst different ethnicities in Trinidad.

NCT ID: NCT04774276 Completed - Clinical trials for Coronary Artery Disease

Protocol in Reeducation Occupational Therapist in Coronary Patients

Start date: November 2, 2020
Phase:
Study type: Observational

The quality of life, linked to physical, social and mental performance in people with coronary heart disease represents the primary goals in terms of rehabilitation. This is often developed to meet the expected performance standard in order to give the person effective autonomy. However, is the occupational balance always evaluated? and this management adapted? Does occupational therapist, expert in autonomy and independence in multiple illnesses and disabilities, has a major role to play in cardiac rehabilitation? This area of expertise and the application of occupational therapy to coronary patients seems appropriate, if not necessary. However, there are few scientific studies on the need to include occupational therapy within cardiac rehabilitation protocols.

NCT ID: NCT04772924 Completed - Clinical trials for Coronary Artery Disease

Long-term Fasting in Patients With a History of PCI

Start date: April 20, 2020
Phase: N/A
Study type: Interventional

Patients in this prospective cohort study were selected if they had a history of PCI more than 1 year previously. 405 patients were divided based on their preferences to fasting and non fasting and after 1 month of fasting major adverse cardiovascular events were measured

NCT ID: NCT04767230 Completed - Clinical trials for Coronary Artery Disease

The Effect of a Healthy Diet Containing Flaxseed and Olive Oil on Cardiovascular Disease Risk Markers

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Flaxseed and olive oil consumption have beneficial effects on cardiovascular risk factors. Nonetheless the effects of their simultaneous consumption have not yet been studied.The purpose of this study is to investigate the effects of a healthy diet containing flaxseed and olive oil compared with healthy dietary advice on cardiovascular disease risk markers in patients with coronary artery disease (CAD), in improving flow-mediated dilation, plasma lipid profile and fatty acids composition of red blood cells.

NCT ID: NCT04766749 Completed - Clinical trials for Coronary Artery Disease

Remote Ischemic Preconditioning on the Prognosis of Patients With Elective PCI Using Drug-coated Balloon

RIPC-DCB
Start date: February 24, 2021
Phase: N/A
Study type: Interventional

Drug-coated balloon is being used more and more widely for the advantage of intervention without implantation. But the balloon needs to be released long enough to be effective. Prolonged balloon dilation resulting in the cessation of blood flow in the distal vessels, especially large vessels, may result in severe ischemia in the patient. RIPC can enhance patients' tolerance to ischemic events, so we believe that RIPC application before the use of drug balloon for PCI can improve patients' ischemic symptoms, thus increasing the release time of drug balloon and improving the effect.

NCT ID: NCT04763629 Completed - Hypertension Clinical Trials

Effects of Different Exercise Training on Atrial Function in Hypertension

TACITO
Start date: January 20, 2021
Phase: N/A
Study type: Interventional

The study aim is to compare the effects produced by two different exercise training modalities on atrial function evaluated by speckle-tracking echocardiography on hypertensive patients with coronary artery disease. 50 males patients will be randomized to interval training or combined training the latter including both aerobic and resistance exercises. The training period will last 12 weeks. The protocol will provide two different assessment of atrial function: -acute: after a single session of exercise; - 12 weeks: at the end of exercise training protocols.

NCT ID: NCT04754880 Completed - Clinical trials for Coronary Artery Disease

Coronary Chronic Total Occlusion and Oxidative Balance

Start date: January 1, 2018
Phase:
Study type: Observational

The presence of chronic blockage of coronary arteries, which we may accept as the terminal point of atherosclerotic coronary artery disease, is closely associated with a poor prognosis. The Discovery of markers that may distinguish patients with a high risk of chronic total occlusion development among patients monitored with the diagnosis of stable coronary artery disease may be important for being able to reduce the increased mortality and morbidity rates. Oxidative stress status may be one of the markers that play a role in and/or show the development of chronic total occlusion. It was reported that it has a role in the progression, erosion, and instability of atherosclerotic plaques in coronary arteries. To the best of our knowledge, the relationship between chronic total occlusion development and oxidative stress status in stable coronary artery disease has not been studied. This study investigated the relationships in the oxidative stress status evaluated over TAS, TOS, OSI, Thiol/Disulfide Homeostasis, and antioxidative vitamin levels and possible differences in patients with noncritical coronary artery disease and those with chronic total occlusion.

NCT ID: NCT04753372 Completed - Clinical trials for Coronary Artery Disease (CAD)

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Start date: December 21, 2020
Phase:
Study type: Observational [Patient Registry]

Registry to describe the impact in terms of effectiveness and safety of the combination treatment of rivaroxaban 2.5 mg twice daily with aspirin on clinical outcomes and practices in a real-life Dutch patient population that are at high risk of ischemic events.